Feb 5 (Reuters) - Medical device maker Boston Scientific (BSX.N), opens new tab forecast annual profit above Wall Street estimates on Wednesday, banking on steady demand for its heart devices.

Commanding a market cap of $150.9 billion, Boston Scientific Corporation (BSX) is a global medical device manufacturer that develops, manufactures, and markets a broad range of innovative products.

Brinker International, Business First Bancshares, AZEK, Celestica and Boston Scientific have been highlighted in this Screen of The Week article. We recently published a list of the 10 Best ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

In a report released today, Josh Jennings from TD Cowen maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $110.00. The company’s shares closed ...

Bringing Pittcon to Boston represents a perfect alignment of mission and location,” said Heather Juzwa, President of Pittcon 2025. “The city’s concentration of scientific talent, from ...

To supplement our unaudited consolidated financial statements presented on a GAAP basis, we disclose certain non-GAAP financial measures, including adjusted net income (loss), adjusted net income ...

Photos of popular singer Neha Kakkar appearing to be arrested by the police recently went viral on social media, sparking widespread speculation. However, it was later confirmed that these images ...

Neha was stabbed to death on April 18, 2024, by Fayaz, a fellow student, allegedly in retaliation for rejecting his marriage proposal The murder of 22-year-old Neha Hiremath, a student at BVB ...